Cargando…

PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors

PURPOSE: Radiation therapy is a standard modality in the treatment for cancers of the head and neck, but is associated with significant short- and long-term side effects. Proton therapy, with its unique physical characteristics, can deliver less dose to normal tissues, resulting in fewer side effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Alexander, Chang, John H. C., Grover, Ryan S., Hoebers, Frank J. P., Parvathaneni, Upendra, Patel, Samir H., Thariat, Juliette, Thomson, David J., Langendijk, Johannes A., Frank, Steven J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Particle Therapy Co-operative Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270078/
https://www.ncbi.nlm.nih.gov/pubmed/34285938
http://dx.doi.org/10.14338/IJPT-20-00071.1
_version_ 1783720724456800256
author Lin, Alexander
Chang, John H. C.
Grover, Ryan S.
Hoebers, Frank J. P.
Parvathaneni, Upendra
Patel, Samir H.
Thariat, Juliette
Thomson, David J.
Langendijk, Johannes A.
Frank, Steven J.
author_facet Lin, Alexander
Chang, John H. C.
Grover, Ryan S.
Hoebers, Frank J. P.
Parvathaneni, Upendra
Patel, Samir H.
Thariat, Juliette
Thomson, David J.
Langendijk, Johannes A.
Frank, Steven J.
author_sort Lin, Alexander
collection PubMed
description PURPOSE: Radiation therapy is a standard modality in the treatment for cancers of the head and neck, but is associated with significant short- and long-term side effects. Proton therapy, with its unique physical characteristics, can deliver less dose to normal tissues, resulting in fewer side effects. Proton therapy is currently being used for the treatment of head and neck cancer, with increasing clinical evidence supporting its use. However, barriers to wider adoption include access, cost, and the need for higher-level evidence. METHODS: The clinical evidence for the use of proton therapy in the treatment of head and neck cancer are reviewed here, including indications, advantages, and challenges. RESULTS: The Particle Therapy Cooperative Group Head and Neck Subcommittee task group provides consensus guidelines for the use of proton therapy for head and neck cancer. CONCLUSION: This report can be used as a guide for clinical use, to understand clinical trials, and to inform future research efforts.
format Online
Article
Text
id pubmed-8270078
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Particle Therapy Co-operative Group
record_format MEDLINE/PubMed
spelling pubmed-82700782021-07-19 PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors Lin, Alexander Chang, John H. C. Grover, Ryan S. Hoebers, Frank J. P. Parvathaneni, Upendra Patel, Samir H. Thariat, Juliette Thomson, David J. Langendijk, Johannes A. Frank, Steven J. Int J Part Ther Clinical PURPOSE: Radiation therapy is a standard modality in the treatment for cancers of the head and neck, but is associated with significant short- and long-term side effects. Proton therapy, with its unique physical characteristics, can deliver less dose to normal tissues, resulting in fewer side effects. Proton therapy is currently being used for the treatment of head and neck cancer, with increasing clinical evidence supporting its use. However, barriers to wider adoption include access, cost, and the need for higher-level evidence. METHODS: The clinical evidence for the use of proton therapy in the treatment of head and neck cancer are reviewed here, including indications, advantages, and challenges. RESULTS: The Particle Therapy Cooperative Group Head and Neck Subcommittee task group provides consensus guidelines for the use of proton therapy for head and neck cancer. CONCLUSION: This report can be used as a guide for clinical use, to understand clinical trials, and to inform future research efforts. The Particle Therapy Co-operative Group 2021-06-25 /pmc/articles/PMC8270078/ /pubmed/34285938 http://dx.doi.org/10.14338/IJPT-20-00071.1 Text en ©Copyright 2021 The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Distributed under Creative Commons CC-BY (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Clinical
Lin, Alexander
Chang, John H. C.
Grover, Ryan S.
Hoebers, Frank J. P.
Parvathaneni, Upendra
Patel, Samir H.
Thariat, Juliette
Thomson, David J.
Langendijk, Johannes A.
Frank, Steven J.
PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors
title PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors
title_full PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors
title_fullStr PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors
title_full_unstemmed PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors
title_short PTCOG Head and Neck Subcommittee Consensus Guidelines on Particle Therapy for the Management of Head and Neck Tumors
title_sort ptcog head and neck subcommittee consensus guidelines on particle therapy for the management of head and neck tumors
topic Clinical
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270078/
https://www.ncbi.nlm.nih.gov/pubmed/34285938
http://dx.doi.org/10.14338/IJPT-20-00071.1
work_keys_str_mv AT linalexander ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors
AT changjohnhc ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors
AT groverryans ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors
AT hoebersfrankjp ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors
AT parvathaneniupendra ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors
AT patelsamirh ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors
AT thariatjuliette ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors
AT thomsondavidj ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors
AT langendijkjohannesa ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors
AT frankstevenj ptcogheadandnecksubcommitteeconsensusguidelinesonparticletherapyforthemanagementofheadandnecktumors